Clinical Trials on Heart; Disease, Mitral(Valve) in Japan

Total 1549 results

National Cerebral and Cardiovascular Center

Recruiting

Japanese Lead Extraction Registry (J-LEX)

Arrhythmia, Cardiac

Japan
Biotronik Japan, Inc.

Completed

Safety and Efficacy Study of IPG Patient With Home Monitoring

Bradyarrhythmia

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Catheter Ablation Registry (J-AB)

Cardiac Arrhythmias | Catheter Ablation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
National Cerebral and Cardiovascular Center

Unknown

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring (OPTIMAL)

Coronary Atherosclerosis

Japan
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS (STOPDAPT-2 ACS)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Platelet Aggregation Inhibitors

Japan
Sapporo Medical University
Merck Sharp & Dohme LLC

Completed

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Coronary Artery Disease

Japan
Kobe University

Unknown

Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound (ANTARES)

Coronary Artery Disease | Angina Pectoris

Japan
Kyoto Prefectural University of Medicine

Unknown

Anti-Restenosis After AMI by Erythropoietin

Acute Myocardial Infarction

Japan
Associations for Establishment of Evidence in Interventions

Unknown

Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation Stents (J-LESSON)

Coronary Artery Disease

Japan
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)

Coronary Artery Disease

Japan
Teva takeda

Active, not recruiting

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

Hypertension

Japan
Boehringer Ingelheim

Completed

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Hypertension

Japan
Kumamoto University
Japan Heart Foundation

Completed

Pilot Study of Edaravone to Treat Acute Myocardial Infarction

Myocardial Infarction | Reperfusion Injury

Japan
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Jichi Medical University

Completed

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home) (Asia BP@Home)

Hypertension

Japan
Novartis

Completed

SPP100 Dose Finding Study in Japan

Hypertension

Japan
Jichi Medical University

Completed

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

Hypertension

Japan
Yokohama City University Medical Center
Teikyo University

Completed

Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS) (VAMPIRE3)

Coronary Artery Disease

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Severe Hypertension

Severe Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Essential Hypertension

Japan
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Novartis

Completed

A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

Hypertension

Japan
Tokyo University

Completed

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine (ONEAST)

Essential Hypertension

Japan
Kumamoto University

Completed

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study (CALDERA-PCI)

Stable Angina

Japan
Kobe University

Unknown

The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography (ALTAIR)

Coronary Artery Disease | Thin-cap fIbroatheroma

Japan
Alcon Research

Completed

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

Glaucoma

Japan
Kobe University

Unknown

Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

Coronary Artery Disease | Angina Pectoris

Japan
Tokorozawa Heart Center
University Hospital Inselspital, Berne

Active, not recruiting

A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI (CONNECT)

STEMI - ST Elevation Myocardial Infarction

Japan
Okayama University
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Completed

Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy (TICAP-DCM)

Dilated Cardiomyopathy

Japan
Associations for Establishment of Evidence in Interventions
Medtronic Vascular

Completed

A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

Coronary Artery Disease | Drug-eluting Stent

Japan
CAVI-J Study Group
Okayama University; Dokkyo Medical University; Ehime University Graduate School... and other collaborators

Completed

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan (CAVI-J)

Stroke | Cardiovascular Death | Nonfatal Myocardial Infarction

Japan
Cook Group Incorporated

Completed

Zilver Flex Post-Market Study in Japan

Peripheral Arterial Disease (PAD)

Japan
Sanofi

Completed

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease (PAD)

Japan
National Cerebral and Cardiovascular Center

Recruiting

REASSURE-NIRS Registry (REASSURENIRS)

Lipid-Rich Atherosclerosis of Coronary Artery

Japan
Novo Nordisk A/S

Completed

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Healthy Volunteers | Atherosclerotic Cardiovascular Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Arrhythmia

Japan
Yokohama City University Medical Center

Unknown

The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

Coronary Disease | Hypercholesterolemia

Japan
Novartis

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

Essential Hypertension

Japan
Kyoto University

Completed

Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Essential Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Hypertension

Japan
Astellas Pharma Inc

Completed

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

Coronary Artery Disease | Hypercholesteremia

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan
Bristol-Myers Squibb
Pfizer

Completed

Evaluation of Safety and Effectiveness on Oral Anticoagulants (RCR-OAC)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate

Atrial Fibrillation

Japan

3

Subscribe